Gayathri Anandappa

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.

Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 13, 2024

Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study.

Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 24, 2024

New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis.

New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis.

Journal: Research square

Published: October 27, 2023

New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis.

New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis.

Journal: BJC reports

Published: October 12, 2023

Genetic and immune landscape evolution in MMR-deficient colorectal cancer.

Genetic and immune landscape evolution in MMR-deficient colorectal cancer.

Journal: The Journal of pathology

Published: June 23, 2023

Next-Generation Approaches to Immuno-Oncology in GI Cancers.

Next-Generation Approaches to Immuno-Oncology in GI Cancers.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: June 08, 2023

Immune checkpoint therapy-current perspectives and future directions.

Immune checkpoint therapy-current perspectives and future directions.

Journal: Cell

Published: January 27, 2023

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).

Journal: BMC cancer

Published: January 26, 2023

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer.

Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer.

Journal: Cell reports. Medicine

Published: January 18, 2023

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).

Journal: ESMO open

Published: May 25, 2022

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial.

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition-Induced Hypertension: The HYPAZ Trial.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 29, 2021

Panitumumab Alone for Maintenance Treatment in Advanced Colorectal Cancer.

Panitumumab Alone for Maintenance Treatment in Advanced Colorectal Cancer.

Journal: JAMA oncology

Published: July 04, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026